These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 36170764)

  • 21. Outbreak Investigation of COVID-19 Among Residents and Staff of an Independent and Assisted Living Community for Older Adults in Seattle, Washington.
    Roxby AC; Greninger AL; Hatfield KM; Lynch JB; Dellit TH; James A; Taylor J; Page LC; Kimball A; Arons M; Munanga A; Stone N; Jernigan JA; Reddy SC; Lewis J; Cohen SA; Jerome KR; Duchin JS; Neme S
    JAMA Intern Med; 2020 Aug; 180(8):1101-1105. PubMed ID: 32437547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel Surveillance System Implementation and Evaluation for SARS-CoV-2 Genomic Data, Washington, USA, 2020-2021.
    Oltean HN; Allen KJ; Frisbie L; Lunn SM; Torres LM; Manahan L; Painter I; Russell D; Singh A; Peterson JM; Grant K; Peter C; Cao R; Garcia K; Mackellar D; Jones L; Halstead H; Gray H; Melly G; Nickerson D; Starita L; Frazar C; Greninger AL; Roychoudhury P; Mathias PC; Kalnoski MH; Ting CN; Lykken M; Rice T; Gonzalez-Robles D; Bina D; Johnson K; Wiley CL; Magnuson SC; Parsons CM; Chapman ED; Valencia CA; Fortna RR; Wolgamot G; Hughes JP; Baseman JG; Bedford T; Lindquist S
    Emerg Infect Dis; 2023 Feb; 29(2):242-251. PubMed ID: 36596565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
    Thompson MG; Natarajan K; Irving SA; Rowley EA; Griggs EP; Gaglani M; Klein NP; Grannis SJ; DeSilva MB; Stenehjem E; Reese SE; Dickerson M; Naleway AL; Han J; Konatham D; McEvoy C; Rao S; Dixon BE; Dascomb K; Lewis N; Levy ME; Patel P; Liao IC; Kharbanda AB; Barron MA; Fadel WF; Grisel N; Goddard K; Yang DH; Wondimu MH; Murthy K; Valvi NR; Arndorfer J; Fireman B; Dunne MM; Embi P; Azziz-Baumgartner E; Zerbo O; Bozio CH; Reynolds S; Ferdinands J; Williams J; Link-Gelles R; Schrag SJ; Verani JR; Ball S; Ong TC
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):139-145. PubMed ID: 35085224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronavirus Disease 2019 (COVID-19) Outbreak Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) P.1 Lineage in a Long-Term Care Home After Implementation of a Vaccination Program-Ontario, Canada, April-May 2021.
    Williams C; Al-Bargash D; Macalintal C; Stuart R; Seth A; Latham J; Gitterman L; Fedsin S; Godoy M; Kozak R; Guthrie JL; Wood H; McGeer A; Hota S; Rea E
    Clin Infect Dis; 2022 Mar; 74(6):1085-1088. PubMed ID: 34240103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study.
    McKeigue PM; McAllister DA; Hutchinson SJ; Robertson C; Stockton D; Colhoun HM
    Lancet Respir Med; 2022 Jun; 10(6):566-572. PubMed ID: 35227416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National Population.
    Butt AA; Talisa VB; Yan P; Shaikh OS; Omer SB; Mayr FB
    Clin Infect Dis; 2022 Aug; 75(1):e579-e584. PubMed ID: 35245940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance.
    Cao L; Lou J; Chan SY; Zheng H; Liu C; Zhao S; Li Q; Mok CKP; Chan RWY; Chong MKC; Wu WKK; Chen Z; Wong ELY; Chan PKS; Zee BCY; Yeoh EK; Wang MH
    Nat Med; 2022 Aug; 28(8):1715-1722. PubMed ID: 35710987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA.
    Keyel AC; Russell A; Plitnick J; Rowlands JV; Lamson DM; Rosenberg E; St George K
    Emerg Infect Dis; 2022 Oct; 28(10):1990-1998. PubMed ID: 36048774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variants of Concern Are Overrepresented Among Postvaccination Breakthrough Infections of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Washington State.
    McEwen AE; Cohen S; Bryson-Cahn C; Liu C; Pergam SA; Lynch J; Schippers A; Strand K; Whimbey E; Mani NS; Zelikoff AJ; Makarewicz VA; Brown ER; Bakhash SAM; Baker NR; Castor J; Livingston RJ; Huang ML; Jerome KR; Greninger AL; Roychoudhury P
    Clin Infect Dis; 2022 Mar; 74(6):1089-1092. PubMed ID: 34166484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of SARS-CoV-2 Among Residents and Staff Members of an Independent and Assisted Living Community for Older Adults - Seattle, Washington, 2020.
    Roxby AC; Greninger AL; Hatfield KM; Lynch JB; Dellit TH; James A; Taylor J; Page LC; Kimball A; Arons M; Schieve LA; Munanga A; Stone N; Jernigan JA; Reddy SC; Lewis J; Cohen SA; Jerome KR; Duchin JS; Neme S
    MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(14):416-418. PubMed ID: 32271726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variation in SARS-CoV-2 Prevalence in U.S. Skilled Nursing Facilities.
    White EM; Kosar CM; Feifer RA; Blackman C; Gravenstein S; Ouslander J; Mor V
    J Am Geriatr Soc; 2020 Oct; 68(10):2167-2173. PubMed ID: 32674223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants and Risk of Coronavirus Disease 2019 (COVID-19) Hospitalization Among Confirmed Cases in Washington State: A Retrospective Cohort Study.
    Paredes MI; Lunn SM; Famulare M; Frisbie LA; Painter I; Burstein R; Roychoudhury P; Xie H; Mohamed Bakhash SA; Perez R; Lukes M; Ellis S; Sathees S; Mathias PC; Greninger A; Starita LM; Frazar CD; Ryke E; Zhong W; Gamboa L; Threlkeld M; Lee J; McDermot E; Truong M; Nickerson DA; Bates DL; Hartman ME; Haugen E; Nguyen TN; Richards JD; Rodriguez JL; Stamatoyannopoulos JA; Thorland E; Melly G; Dykema PE; MacKellar DC; Gray HK; Singh A; Peterson JM; Russell D; Torres LM; Lindquist S; Bedford T; Allen KJ; Oltean HN
    Clin Infect Dis; 2022 Aug; 75(1):e536-e544. PubMed ID: 35412591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a preliminary assessment from a case-control study in St. Petersburg, Russia.
    Barchuk A; Bulina A; Cherkashin M; Berezina N; Rakova T; Kuplevatskaya D; Stanevich O; Skougarevskiy D; Okhotin A
    BMC Public Health; 2022 Sep; 22(1):1803. PubMed ID: 36138385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effects of prior third dose mRNA vaccination in rural nursing home residents during SARS-CoV-2 outbreaks.
    Rhynold ES; Quan S; Orr PH; LaBine L; Singer A; St John PD
    J Am Geriatr Soc; 2022 Nov; 70(11):3245-3249. PubMed ID: 35938635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poor Antibody Response to BioNTech/Pfizer Coronavirus Disease 2019 Vaccination in Severe Acute Respiratory Syndrome Coronavirus 2-Naive Residents of Nursing Homes.
    Pannus P; Neven KY; De Craeye S; Heyndrickx L; Vande Kerckhove S; Georges D; Michiels J; Francotte A; Van Den Bulcke M; Zrein M; Van Gucht S; Schmickler MN; Verbrugghe M; Matagne A; Thomas I; Dierick K; Weiner JA; Ackerman ME; Goriely S; Goossens ME; Ariën KK; Desombere I; Marchant A
    Clin Infect Dis; 2022 Aug; 75(1):e695-e704. PubMed ID: 34864935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Against the Delta Variant.
    Risk M; Shen C; Hayek SS; Holevinski L; Schiopu E; Freed G; Akin C; Zhao L
    Clin Infect Dis; 2022 Aug; 75(1):e623-e629. PubMed ID: 35137006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021.
    Teran RA; Walblay KA; Shane EL; Xydis S; Gretsch S; Gagner A; Samala U; Choi H; Zelinski C; Black SR
    MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):632-638. PubMed ID: 33914721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A SARS-CoV-2 Outbreak Among Nursing Home Residents Vaccinated with a Booster Dose of mRNA COVID-19 Vaccine.
    Ripabelli G; Sammarco ML; Rezza G; D'Amico A; De Dona R; Iafigliola M; Parente A; Samprati N; Santagata A; Adesso C; Natale A; Di Palma MA; Cannizzaro F; Dentizzi C; Stefanelli P; Tamburro M
    J Community Health; 2022 Aug; 47(4):598-603. PubMed ID: 35334031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct and Indirect Effectiveness of mRNA Vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 in Long-Term Care Facilities, Spain.
    Monge S; Olmedo C; Alejos B; Lapeña MF; Sierra MJ; Limia A;
    Emerg Infect Dis; 2021 Oct; 27(10):2595-2603. PubMed ID: 34314670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.